New Evidence Suggests Medicinal Cannabis Does Not Treat Mental Illnesses
The video examines a new Lancet Psychiatry review that concludes medicinal cannabis offers no therapeutic benefit for anxiety, depression, or PTSD and may even exacerbate these conditions. The analysis arrives amid a surge in Australian prescriptions, with more than 700,000 patients receiving cannabis, 60% of whom are being treated for mental‑health problems, fueling a market estimated at around one billion dollars annually. The study highlights a stark lack of robust evidence for cannabis in treating ADHD, bipolar disorder, and OCD, and points to modest or negative outcomes for the primary mental‑health indications. Despite these findings, prescribing rates remain high, driven in part by aggressive marketing on social media and clinics that churn out dozens of prescriptions per hour, raising concerns about clinical oversight. Interviewees in the video note that the push for medicinal cannabis appears ideologically motivated rather than evidence‑based. One commentator acknowledges limited, controlled micro‑dosing may help with chronic pain but rejects its use for mood disorders. Others warn that unchecked advertising and rapid prescription practices risk patient safety and undermine medical standards. If policymakers act on the study’s conclusions, Australia could see tighter prescribing guidelines, stricter regulation of cannabis‑focused clinics, and a potential contraction of the lucrative industry. Clinicians may need to reassess treatment plans, and investors could face heightened scrutiny as the market adjusts to evidence‑driven constraints.
Atrial Fibrillation Therapy in Patients with Stents (ADAPT AF-DES)
The New England Journal of Medicine’s ADAPT AF‑DES trial examined whether a non‑vitamin K antagonist oral anticoagulant (NOAC) alone could safely replace the conventional dual antithrombotic regimen of NOAC plus clopidogrel in patients with atrial fibrillation who had received a...
How Your Kidneys Actually Work — and What Happens when They Fail
The video explains how kidneys act as the body’s filtration system, processing roughly 150 quarts of blood each day through millions of microscopic units called nephrons. It breaks down the two‑part structure—glomerulus and tubule—and shows how waste is removed while...
Why NHS Innovation Stalls
The Digital Health Unplugged episode examines why innovation stalls in the NHS, featuring Mindy Simon of the NHS Innovation Accelerator and Alina Nenova, CEO of Feebris, to unpack scaling challenges and systemic lessons. They stress that robust evidence of cost‑effectiveness and...
Unexpected Bleeding? Get Seen. But Don't Panic. | Felice Gersh, MD
Dr. Felice Gersh explains the distinction between simple and atypical uterine hyperplasia, emphasizing how each condition relates to future cancer risk. Simple hyperplasia is characterized by an overgrowth of normal‑appearing cells and carries a very low probability—less than five percent...
I Take Uterine Cancer Seriously and You Should Too! Even Though the Risk Is Small | Felice Gersh, MD
Dr. Felice Gersh, MD, uses this brief video to highlight uterine (endometrial) cancer as a disease that overwhelmingly targets postmenopausal women, especially those over 40. She notes that more than 95% of cases arise in women who are not on...
Who Do Americans Trust for Health Info?
The University of Pennsylvania’s latest public‑opinion poll asks a simple question: who does the American public trust for health information? The survey of 1,600 adults reveals a stark erosion of confidence in federal health agency leadership, with just five percent...
Why Lockdown May Have Left Young People Vulnerable to Meningitis
A deadly meningitis outbreak in Kent, which claimed two lives, has been traced to gaps in routine teenage vaccinations caused by pandemic‑era school closures. The suspension of school‑based immunisation programmes left roughly four in ten adolescents without protection against the...
A Chat with the Impressive Mary Hawking - GP and Clinical Informatician
In this episode of Everything Digital Health, veteran GP and clinical informatician Mary Hawking recounts a career that spans pediatric training in the United States, a brief stint in transplant medicine, and a return to UK general practice in the...
Religious Liberty Commission, Sixth Hearing
The Religious Liberty Commission opened its sixth hearing, chaired by Texas Lieutenant Governor Dan Patrick and opened with a prayer by Reverend Franklin Graham. Assistant Secretary for Health Brian Kirsten outlined the commission’s purpose, tracing religious liberty to America’s founding...
Father Unknown? Life as a Sperm Donor's Child | DW Documentary
The DW documentary explores the growing landscape of sperm donation in Europe, focusing on single women who choose motherhood without a partner and the men who supply the genetic material. Sweden’s 2016 law allowing single women to access state‑funded sperm...
Building AI for Better Healthcare — the OpenAI Podcast Ep. 14
The OpenAI Podcast’s fourteenth episode spotlights OpenAI’s health‑focused AI program, led by Dr. Nate Gross and Karan Singhal. They discuss how large language models are being engineered to answer sensitive medical questions, support clinicians, and streamline fragmented care. OpenAI built ChatGPT...
594 - Building Frictionless Healthcare: Updoc’s Journey to Improving Healthcare Access
The Talking Health Tech podcast episode spotlights UPDoc, a digital‑first primary‑care service that lets patients request prescriptions, referrals, and medical letters through a web or app interface. Users either subscribe or pay per consultation, after which their request joins a...
NEJM Clinician: Apixaban Vs. Rivaroxaban for Acute VTE
The New England Journal of Medicine published a head‑to‑head trial evaluating apixaban (Eliquis) against rivaroxaban (Xarelto) in 2,800 patients with acute pulmonary embolism or deep‑vein thrombosis. The study provides the first direct comparative safety and efficacy data for these two...
Johns Hopkins Psychiatry Grand Rounds | Preteen Suicide Assessment
Johns Hopkins psychiatrists present a five‑year NIMH‑funded study developing a reliable, developmentally appropriate assessment for suicidal thoughts and behaviors in children ages eight to twelve. The initiative grew from a 2021 NIMH call to address the emerging public‑health crisis of...
Johns Hopkins Psychiatry Grand Rounds | Mild Behavioral Impairment (MBI)
The Grand Rounds presentation introduced Mild Behavioral Impairment (MBI) as a framework for understanding neuropsychiatric symptoms that emerge before overt dementia, using a 72‑year‑old patient with late‑onset depression and subsequent Alzheimer’s pathology as a case study. The speaker highlighted that...
The US Dietary Guidelines Debate: Science, Politics & Ultra-Processed Foods | Gardner & Beal
The podcast brings together Stanford nutritionist Dr. Christopher Gardner and Global Alliance for Improved Nutrition’s Dr. Tai Beal to dissect the latest U.S. Dietary Guidelines, exposing how scientific input is routinely sidelined by political actors. They highlight that the advisory...
Build vs Buy: How Is AI Changing the Equation?
The video tackles the growing "build versus buy" dilemma in healthcare IT, focusing on how artificial intelligence is reshaping the calculus for CIOs and executives. With major vendors charging premium prices for AI‑enhanced platforms, leaders are questioning whether the perceived...
Are We Prepared for the Workforce Changes AI Might Bring?
The video examines how artificial intelligence is poised to transform labor‑intensive functions, from call‑center operations to routine tasks in healthcare. It argues that AI‑driven automation will soon make human provisioning and after‑hours access management obsolete, prompting a wave of job...
Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.
In a recent Life Science Leader interview, Marc Hedrick, M.D., President and CEO of Plus Therapeutics, outlined the company’s strategic shift toward radiotherapeutics targeting central nervous system (CNS) malignancies. The discussion centered on the lead asset, Rayobic, a Re‑186 beta‑emitting...
NYC Health Commissioner: Federal Government Is Creating 'a Public Health Disaster'
The New York City Health Commissioner warned that the federal administration’s approach to vaccine guidance is precipitating a public‑health disaster, accusing Washington of abandoning science‑based policy and undermining trust in proven immunizations. He highlighted specific actions: the city’s withdrawal from the...
How Good Are Early Cancer Detection Tests?
The video examines the clinical performance of a widely promoted early‑cancer detection blood test, focusing on its ability to identify malignancies at a stage where intervention could be curative. In a cohort of 6,600 participants, the assay flagged 92 individuals, but...
How the Mexican Cartels Took over the US Opioid Crisis | DW Documentary
DW’s documentary traces how Mexican drug cartels seized the United States’ opioid crisis by flooding the market with lab‑produced fentanyl. The film links the 1990s wave of overprescribed painkillers to a desperate pool of addicts who turned to illicit alternatives...
Leveling ‘Lopsided Law’: Dov Fox on Conscience in Health Care and Medical Practice
The event featured Professor Dov Fox discussing the stark legal asymmetry surrounding clinician conscience. He highlighted that current conscience clauses shield doctors who refuse to perform certain procedures—such as abortions or gender‑affirming care—while offering no comparable protection for clinicians who...
CEO Stephen From Is Building Tested Strategies Into a New Plan To...
The episode centers on Stephen, the newly appointed CEO of Vicarius Surgical, who argues that the company should be viewed primarily as a medical‑device firm rather than a pure robotics play. He outlines a “tested strategies” framework that prioritizes regulatory...
Assessing the U.S. Medical Innovation System
The NBER‑sponsored event titled “Assessing the U.S. Medical Innovation System” convened economists, health‑policy scholars, and industry experts to examine how public funding mechanisms shape biomedical research. Organizers highlighted the central question: does the NIH peer‑review process penalize investigators who...
Health Reporters React to "The Fugitive"
The video features health journalists using the 1993 thriller “The Fugitive” as a springboard to explore how a fictional pharmaceutical scandal would be reported today. They walk through the plot’s central drug, Provasic—originally called RDU90—described as a revolutionary, side‑effect‑free arterial...
The Future of Vaccines
The Stanford Engineering podcast “The Future of Everything” hosted a conversation with Stanford professor Bonnie Maldonado about the past, present, and future of vaccines. Maldonado traced vaccine history from 19th‑century experiments to today’s global immunization programs, emphasizing how vaccination...
Ethical Challenges for Mental Health Professionals | Jack P. Haynes Spotlight
In a recent Spotlight interview, APA‑affiliated psychologist Jack P. Haynes, a former ethics‑committee chair, introduces his new co‑authored volume, *Ethical Challenges for Mental Health Professionals: Your Questions Answered*. The book is positioned as a practical guide for clinicians across disciplines—psychologists,...
Global Medical Data Infrastructure for AI Systems with MedSyntra - Life Sciences Today Podcast Ep 52
The Life Sciences Today podcast introduced Medentra, a Tel‑Aviv‑based startup building a global infrastructure that transforms fragmented radiology and imaging data into AI‑ready assets for research and clinical use. Medentra’s platform normalizes DICOM files, strips proprietary tags, and fully de‑identifies patient...
Is Medicare Broken? Inside CMS Reforms, Medicare Advantage, and Healthcare Costs
The interview centers on the Center for Medicare and Medicaid Services’ (CMS) sweeping reforms, from site‑neutral payment rules to new Medicare Advantage models, and how these changes aim to curb waste in a system that now commands $1.7 trillion in outlays....
Best Patient Impact of the Year| Synchrony Medical Wins at MedTech World Middle East 2026
Synchrony Medical was honored with the Best Patient Impact of the Year award at MedTech World Middle East 2026, highlighting its newly launched device that targets unmet clinical needs. The accolade underscores the company’s rapid ascent in the med‑tech landscape...
Group Papa - Local Medical Guidelines
A project led by Medical Action Myanmar aims to replace static PDF medical guidelines with a lightweight progressive web app. The system will let local health teams author, distribute, and update guidelines on low‑powered devices with limited connectivity. It incorporates...
FDA & Rare Disease Drugs: Why Policy and Politics Are Heating Up
The episode focuses on the FDA’s new draft guidance designed to streamline approval pathways for ultra‑rare, often single‑patient, therapies. Host Jeff Buyers and guest Leslie Erlac discuss the policy shift against the backdrop of recent leadership turmoil, notably the departure...
The Resurgence of Measles in the United States | CommonHealth Live!
The United States is seeing a sharp rise in measles, with over 3,000 confirmed cases since January 2025 and nearly 1,000 reported in South Carolina alone during the first two months of 2026. Pertussis cases also surged to about 30,000...
Rethinking Healthcare’s Carbon Footprint and Environmental Impact
The video spotlights the staggering environmental burden of modern healthcare, noting that if the sector were a nation it would rank as the world’s fifth‑largest greenhouse‑gas emitter. In Australia alone, health services generate roughly seven percent of the country’s total...
How I Really Feel About the FDA
The video captures a candid interview with the FDA commissioner, highlighting a newly perceived friendliness toward peptide‑based therapies and fast‑track pathways. The conversation marks a departure from the regulator’s historically cautious posture, suggesting a more collaborative environment for emerging biotech...
Pulse Check: The New U.S-Africa Health Deals
By early 2026, more than a dozen African countries have signed nearly $20 billion in bilateral health agreements under the Trump administration’s America First Global Health Strategy. The initiative shifts U.S. assistance from multilateral channels to direct country‑to‑country deals, promising rapid...
Progesterone Is Neuroprotective: One More Reason All Women in Menopause Benefit | Felice Gersh, MD
The video explains how progesterone, beyond its reproductive role, acts as a neuroprotective agent—an insight especially relevant for women navigating menopause. By crossing the lipophilic blood‑brain barrier, the hormone can directly influence central nervous system processes. Key mechanisms highlighted include reduction...
Vaccines and Related Biological Products Advisory Committee Meeting
The FDA's Vaccines and Related Biological Products Advisory Committee convened in open session to discuss and recommend strain composition for the 2026–2027 U.S. influenza vaccines. The meeting opened with roll call introductions from committee members and guest speakers—experts from academia,...
Your Brain Prefers Vaginal Progesterone Because... | Felice Gersh, MD
Dr. Felice Gersh, MD explains that delivering progesterone via the vagina more closely mimics the hormone’s natural surge during the luteal phase of a healthy 23‑year‑old woman’s menstrual cycle. She notes that oral progesterone fails to achieve comparable serum concentrations, while...
Nightly Progesterone Raises Allopregnanolone, Which May Harm Brain Health | Felice Gersh, MD
The video examines how nightly progesterone supplementation elevates the neurosteroid allopregnanolone, a metabolite that strongly modulates the brain’s GABA‑A receptors. Dr. Felice Gersh explains that while GABA activation is essential for sleep, excessive allopregnanolone can produce pronounced sedation, brain‑fog, and...
AI Meets Cell Therapy Manufacturing
Senti Biosciences executives Tim Lu and Claire Aldridge told Cell & Gene Live that artificial intelligence is reshaping cell‑therapy manufacturing by speeding up, not replacing, wet‑lab steps. They highlighted robust validation data that demonstrates AI‑driven processes are reliable. The speakers...
Unlocking AI's Potential in Cell Therapy Through Robust Data
In the closing session of Cell & Gene Live, Senti Biosciences executives Tim Lu and Claire Aldridge argued that a high‑quality, diverse data infrastructure is the cornerstone for applying AI and synthetic biology to cell and gene therapies. They stressed...
Safer, Smarter Cell Therapies with AI
In a Cell & Gene Live segment, Claire Aldridge, Ph.D., emphasized that AI and synthetic biology breakthroughs depend on proprietary, well‑annotated experimental data that continuously train models. Tim Lu, M.D., Ph.D. of Senti Biosciences explained how logic‑gated designs combined with...
AI-Designed Logic Circuits for Smarter Cancer Targeting
Senti Biosciences unveiled an AI‑guided workflow that designs paired activating and inhibitory chimeric antigen receptors (CARs) to create logic‑gated circuits for cell therapies. The system automatically optimizes CAR combinations, enabling more precise discrimination between cancerous and healthy cells and delivering...
DName-iT Eliminating Errors in Testing with a Biotech Blockchain for Diagnostics
DName-iT is deploying patient‑specific molecular barcodes within next‑generation sequencing (NGS) workflows to curb misidentification in cancer and prenatal DNA tests. The approach embeds unique identifiers directly into each DNA fragment, promising lower laboratory costs and higher diagnostic confidence. Pilots are...
How Much Time Can AI Scribes Save? - The Medical Futurist
The video examines AI‑powered medical scribes as a solution to the chronic documentation burden that fuels physician burnout. By passively recording clinical conversations, converting speech to structured notes, and leaving final approval to the clinician, AI scribes promise to eliminate...
Using WHO’s Outbreak Toolkit During Outbreak Investigations
The video introduces the World Health Organization’s Outbreak Toolkit, a standardized suite of forms designed to streamline the investigation and response to infectious disease events. It highlights two core instruments – the T0 form, which records essential epidemiological variables at...
Too Many AI Features, Not Enough Answers
The speaker warns that existing vendors are bombarding their organization with a flood of AI features, many of which lack clear purpose or defined guardrails. This overload is prompting a call for a slower, more deliberate approach to AI adoption,...